Pharmacy Times

In an era of value-based care, optimizing MS treatment requires strategic innovation beyond traditional care models. This Multiple Sclerosis Awareness Month, Mitzi Joi Williams M.D., FAAN, Board-Certified Neurologist and Fellowship Trained MS Specialist, emphasizes their importance as essential partners in comprehensive MS care. "𝘗𝘩𝘢𝘳𝘮𝘢𝘤𝘪𝘴𝘵𝘴 𝘩𝘦𝘭𝘱 𝘸𝘪𝘵𝘩 𝘮𝘦𝘥𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘳𝘦𝘤𝘰𝘯𝘤𝘪𝘭𝘪𝘢𝘵𝘪𝘰𝘯, 𝘦𝘯𝘴𝘶𝘳𝘦 𝘤𝘰𝘳𝘳𝘦𝘤𝘵 𝘥𝘰𝘴𝘪𝘯𝘨, 𝘢𝘯𝘥 𝘪𝘧 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘢𝘳𝘦 𝘩𝘢𝘷𝘪𝘯𝘨 𝘪𝘴𝘴𝘶𝘦𝘴, 𝘩𝘦𝘭𝘱 𝘢𝘥𝘫𝘶𝘴𝘵 𝘵𝘩𝘦𝘪𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘱𝘭𝘢𝘯," shares Dr. Williams, Founder & CEO of Joi Life Wellness Group and advocate for equitable MS care. Pharmacists transform MS patient care through: ✅ Expert medication management that ensures safe and effective therapy. ✅ Precision dosing that maximizes therapeutic benefits while minimizing side effects. ✅ Collaborative treatment adaptation that responds to changing patient needs. Watch Dr. Williams discuss how pharmacists enhance comprehensive MS care. #MSAwarenessMonth #MSEndsWithUs #MSCare #MSAwarenessWeek #Pharmacist #ModernPharmacist #CollaborativePractice #Neurology #MultipleSclerosis

Respiratory syncytial virus (#RSV) hospitalization rates among older adults rise significancy with age, particularly among those with comorbidities and those who are nursing home residents, according to newly published data from older adults in Spain. These findings highlight the need for targeted prevention strategies and improved vaccination efforts to reduce severe outcomes in this vulnerable population. Learn more: https://bit.ly/41M78oH

When a product says “Pharmacist Recommended,” it means trusted by pharmacists…not just anyone on the street. Walter Oronsaye PharmD, MS is reminding us that pharmacists’ expertise drives the Pharmacy Times OTC Guide, the go-to resource for trusted over-the-counter recommendations. The more pharmacists who weigh in, the stronger the guide becomes! #PharmacistRecommended #OTCGuide #PharmacyTimes #PharmacistInsights

As the cost of health care continues to rise, access to life-changing medications remains a pressing issue for patients and providers alike. #GLP-1 receptor agonists have emerged as powerful treatments for #obesity and #type2diabetes, with growing potential for additional therapeutic applications. Despite their clinical benefits, the high cost of these medications—paired with restrictive insurance coverage—has left many patients unable to access them. Learn more: https://bit.ly/4izz9Xh

The #FDA approved SCN-102 (Arbli; Sceinture LLC), the 10-mg/mL oral suspension formulation of losartan potassium (Cozaar; Organon & Co.), for the treatment of adult and pediatric patients aged 6 years and older with hypertension, for the reduction of risk of stroke in patients with hypertension and left ventricular hypertrophy, and for the treatment of diabetic nephropathy in certain patients with #type2diabetes. Learn more: https://bit.ly/43T16oM

Ensitrelvir (Xocova; Shionogi), an oral antiviral treatment approved in Japan to treat mild to moderate #COVID-19, the illness caused by SARS-CoV-2, has demonstrated efficacy in preventing illness in uninfected people with household exposure to the virus, indicating the potential for a convenient postexposure prophylaxis option to prevent a serious disease course. Learn more: https://bit.ly/3FzN5lX

Pharmacists make the game-winning call! 🏆 When it comes to the #1 Pharmacist Recommended Brand®, Crest® was the top toothpaste choice with over 1,800,000 clinical recommendations monthly in 2024. Ready to take your shot? Make your pick in the 2025 survey today: https://bit.ly/3XrJUn9

We love being able to feature pharmacists like Nadia Ahmad, a community pharmacist at Walgreens who make a real impact and stand out in our profession. Her patient-centered approach and ability to find meaning in everyday practice - from compassionately guiding patients through medication challenges to connecting colleagues across global time zones - exemplifies why pharmacy is such a vital healthcare profession. #WomenInPharmacy #Pharmacy #Healthcare #ModernPharmacist

As #biosimilar substitutions become more common, ensuring patient confidence and treatment adherence relies on comprehensive education and counseling from pharmacists, emphasizing the importance of clear communication about efficacy, safety, and regulatory standards. Pharmacists must educate not only themselves but other members of the patient care team as well as patients on regulations, feasibility, and processes surrounding biosimilar substitution. Learn more: https://lnkd.in/eCEJPp9W

The #FDA has approved an expanded indication of eculizumab for pediatric patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody positive, offering a new treatment option for this rare neuromuscular disorder and addressing a significant unmet medical need. This makes eculizumab the first and only treatment available for pediatric patients with gMG. Read more: https://bit.ly/3FncGP0